Preferred Label : Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine;
NCIt definition : A cell-based vaccine composed of autologous lymphoblastoid B cells activated against
Epstein-Barr virus (EBV) in vitro with potential immunoprotective activity. Upon prophylactic
administration, this vaccine may stimulate specific cytotoxic T-lymphocyte (CTL) and
antibody responses against EBV-transformed B cells, thereby preventing an EBV-induced
post-transplantation lymphoproliferative disorder.;
Origin ID : C53443;
UMLS CUI : C1711248;
Semantic type(s)
- concept_is_in_subset
